A Case Report on Zoledronic Acid as Palliative Treatment in Carcinoma of Lung with Bone Metastasis Cover

.blurhash-client-img { display: none !important; }

A Case Report on Zoledronic Acid as Palliative Treatment in Carcinoma of Lung with Bone Metastasis

Forum of Clinical Oncology

Volume 13 (2022): Issue 3 (December 2022)

By: Y. Sandhya, M. Swathi, G. Yeshavanth and V.T. Nagaraja

Open Access

|Jul 2023

Figures & Tables

PET-CT scan from vertex to mid-thigh.a. Neck: Thrombosis of right IJV, right subclavian, and axillary veins with adjacent soft tissue standing.b. Chest: 4.4×3 cm pleural based metabolically active soft tissue in the right upper lobe abutting the adjacent diaphragmatic pleural, likely of neoplastic etiology. Peripheral lung nodule in the apical segment of right lower lobe: metastasisc. Musculoskeletal: Metabolically active lytic lesion involving the left posterior 2nd rib. Degenerative changes are noted in spine.Histopathology report: Left rib lesion biopsy. Features are of metastatic squamous cell carcinoma.

Pain score before treatment with zoledronic acid.

Pain score after treatment with zoledronic acid.

DOI: https://doi.org/10.2478/fco-2023-0001 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Page range: 49 - 51

Submitted on: Sep 8, 2022

Accepted on: Jan 26, 2023

Published on: Jul 4, 2023

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

zoledronic acid,

palliative treatment,

bone metastasis,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2023 Y. Sandhya, M. Swathi, G. Yeshavanth, V.T. Nagaraja, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 13 (2022): Issue 3 (December 2022)Next article